United States· US:85248-136_4a712797-c993-dd8e-e063-6294a90a0592
Beilloso Hyaluronic Acid
A clotrimazole product containing clotrimazole 1 percent hyaluronic acid, registered in United States by Jiangxi Yudexi Pharmaceutical Co., LTD. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Clotrimazole is registered in 2 of 19 countries.
Countries holding a registration under ATC A01AB18 (clotrimazole), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Clotrimazole · ATC A01AB18
2 / 19 countries
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Clotrimazole 1 percent Hyaluronic Acid
- Manufacturer
- Jiangxi Yudexi Pharmaceutical Co., LTD
- Country
- United States (US)
- ATC code
- A01AB18
- ATC class
- Clotrimazole
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11852481360136 g in 1 BOX (85248-136-01)
Regulatory notes
Interactions
592 interactions on record for clotrimazole.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clotrimazole · interactions on record
592 records
- 35 severe
- 240 moderate
- 28 minor
- 289 info
Most severe, free to view
- EliglustatA16AX10severe
- LonafarnibA16AX20severe
- AmiodaroneC01BD01severe
- IvabradineC01EB17severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clotrimazole in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCANDIBENEratiopharm GmbH, Ulm
- PolandCanesten ControlBayer Sp. z o.o.
- NetherlandsCanesten foot crème 10 mg/g, crèmeTop-Pharma B.V.
- SwitzerlandCorisol
- SpainCANESPIE CLOTRIMAZOL 10 mg/g CREMABayer Hispania S.L.
- NorwayCanestenBayer AB - Solna
- FinlandCanesdermBayer Oy
- IrelandCanesten 10 mg/g CreamPCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Candibene, Canesten
- Belgium · Canestene Gyn, Canestene Intim
- Bulgaria · Канестен, Канестен Гин
- Cyprus · Canesten, Mycoril
- Czechia · Candibene, Canesten
- Germany · Antifungol Hexal 3 Vaginalcreme Hexal Ag, Antifungol Hexal Creme
- Denmark · Canesten, Canvag
- Estonia · Canesten, Canifug
- Spain · Canesmed, Canespie
- Finland · Canesderm, Canesten
- France · Clotrimazole Eg Labo Conseil, Mycohydralin
- United Kingdom (Northern Ireland) · Albican, Almus Antifungal
- Greece · Canesten
- Croatia · Canesten, Canesten 3
- Hungary · Candibene, Canesten
- Ireland · Canesten, Canesten Athlete’s Foot
- Iceland · Canesten
- Italy · Antimicotico Same, Candazol
- Lithuania · Canesten, Canifug Cremolum
- Luxembourg · Canestene Gyn, Canestene Intim
- Latvia · Canesten, Canifug Cremolum
- Malta · Canesten, Canesten Combi
- Netherlands · Canesten Foot, Canesten Gyno
- Norway · Canesten, Canesten (Kombinasjonspakning)
- Poland · Canesten, Canesten Control
- Portugal · Candigen, Candiset 3 Dias
- Romania · Canesten, Canesten Gyn 3
- Sweden · Canesten, Clotic
- Slovenia · Canesten, Canesten1
- Slovakia · Candibene, Canesten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b2ebd4d-b27c-411c-80a1-dccebc2e6e53 GET /v1/drugs/2b2ebd4d-b27c-411c-80a1-dccebc2e6e53?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "G07GZ97H65",
"rxcui": "2623",
"inchikey": "VNFPBHJOKIVQEB-UHFFFAOYSA-N",
"display_name": "CLOTRIMAZOLE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "TOPICAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"4a712797-c992-dd8e-e063-6294a90a0592": {
"match": "brand_token",
"title": "BEILLOSO HYALURONIC ACID (CLOTRIMAZOLE 1 PERCENT HYALURONIC ACID) CREAM [JIANGXI YUDEXI PHARMACEUTICAL CO., LTD]",
"spl_version": "1",
"published_date": "2026-02-11"
}
},
"productid": "85248-136_4a712797-c993-dd8e-e063-6294a90a0592",
"productndc": "85248-136",
"dosage_form": "CREAM",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "CLOTRIMAZOLE",
"proprietary_name": "Beilloso Hyaluronic Acid",
"active_ingred_unit": "g/100g",
"application_number": "M005",
"marketing_category": "OTC MONOGRAPH DRUG",
"nonproprietary_name": "Clotrimazole 1 percent Hyaluronic Acid",
"start_marketing_date": "20260210",
"active_numerator_strength": "1"
}See everything about clotrimazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.